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Abstract
Objective: To investigate the associations of organic food consumption with
maternal pre-pregnancy BMI, hypertension and diabetes in pregnancy, and
several blood biomarkers of pregnant women.
Design: Prospective cohort study.
Setting: Pregnant women were recruited at midwives’ practices and through
channels related to consumption of food from organic origin.
Subjects: Pregnant women who ﬁlled in FFQ and donated a blood sample
(n 1339). Participant groups were deﬁned based on the share of consumed
organic products; to discriminate between effects of food origin and food patterns,
healthy diet indicators were considered in some statistical models.
Results: Consumption of organic food was associated with a more favourable
pre-pregnancy BMI and lower prevalence of gestational diabetes. Compared with
participants consuming no organic food (reference group), a marker of dairy
products intake (pentadecanoic acid) and trans-fatty acids from natural origin
(vaccenic and rumenic acids) were higher among participants consuming organic
food (organic groups), whereas elaidic acid, a marker of the intake of trans-fatty
acids found in industrially hydrogenated fats, was lower. Plasma levels of
homocysteine and 25-hydroxyvitamin D were lower in the organic groups than in
the reference group. Differences in pentadecanoic acid, vaccenic acid and vitamin
D retained statistical signiﬁcance when correcting for indicators of the healthy diet
pattern associated with the consumption of organic food.
Conclusions: Consumption of organic food during pregnancy is associated with
several health-related characteristics and blood biomarkers. Part of the observed
associations is explained by food patterns accompanying the consumption of
organic food.
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During the last decades, consumption of organic food (for
a deﬁnition see IFOAM Organics International(1)) has
increased worldwide. In the EU, between 2005 and 2011,
there was a 50% increase in organic farming accompanied
by a considerable growth in sales of organic products on
the internal food market(2). However, the prices of organic
food are in general higher than those of conventionally
produced food. Consumers’ motivation to pay higher
prices for organic food relies in part on environmental
concerns, but also on the conviction that consumption of
organic food might promote health(3). During pregnancy,
health-related concerns become particularly relevant.
Therefore, pregnant women might be especially motivated
to consume organic food.
Within the KOALA Birth Cohort Study (Dutch acronym
for ‘Child, parents, and health: addressing lifestyle and
constitution’), it has been shown that levels of the major
conjugated linoleic acid (CLA) isomer, rumenic acid (RA),
and of its corresponding precursor trans-vaccenic acid
(VA), were higher in the milk of mothers who consumed
organic dairy and ruminant meat products compared with
mothers with a conventional diet(4). Higher levels of these
ruminant fatty acids in mother’s milk, in turn, were shown
to be associated with better atopic outcomes in their
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breast-fed children(5). Moreover, 2-year-old children
consuming milk products almost exclusively from organic
origin had a signiﬁcantly lower risk to develop eczema
compared with children consuming conventional milk
products(6). Despite this evidence and that from some
other promising studies(7,8), more research is warranted on
possible health-related effects of organic food consump-
tion, especially in pregnant women. Interestingly, we
recently showed that the pregnant women in the KOALA
study using food from organic production exhibit speciﬁc
sociodemographic and behavioural characteristics when
compared with those who consume food of conventional
production only(9).
Furthermore, consumption of organic food was asso-
ciated with intake of more products of vegetable origin
(soya/vegetarian products, vegetables, cereal products,
bread, fruits, and legumes) and fewer animal products (milk
and meat), sugar and potatoes than consumed in conven-
tional diets. This translated into healthier food patterns
in the organic groups, which could be conﬁrmed by a
principal component analysis of the consumed food items.
Within the Norwegian cohort study MoBa, a principal
component analysis has been done with similar results(10).
A food pattern with more vegetable food products and less
sweet and alcoholic beverages, processed meat and milk
was also seen in the NutriNet-Santé study(11), while the
German National Nutrition Survey II revealed that persons
who followed an organic diet also consumed more fruits
and vegetables and less meat/sausages and soft drinks(12).
Taken together, these studies indicate that the associations
between consumption of organic food and healthier food
patterns must be considered when studying the inﬂuence of
organic food consumption on health-related characteristics.
Considering this, in the present work we investigated the
associations of organic food consumption with maternal
pre-pregnancy BMI, hypertension and diabetes in preg-
nancy, and several blood biomarkers of pregnant women,
and assessed whether such associations may be related to
the women’s food patterns(9).
Participants and methods
Study design and participants
The KOALA Birth Cohort Study is a prospective cohort
study of mother–infant pairs in the Netherlands, which was
approved by the Medical Ethical Committee of Maastricht
University/Academic Hospital Maastricht (MUMC+ ). All
children’s parents signed for written informed consent.
KOALA is the acronym (in Dutch) for ‘Kind, Ouders en
gezondheid: Aandacht voor Leefstijl en Aanleg’ (Child,
parents and health: addressing lifestyle and constitution).
From October 2000 until December 2002, 2343 preg-
nant women participating in an ongoing prospective
cohort study on Pregnancy-Related Pelvic Girdle Pain
(PPGP) were recruited at midwife practices in the southern
part of the Netherlands(13,14). This number represents
33·4% of the 7020 participating in the PPGP study. The
PPGP study did not use lifestyle-related inclusion criteria
and previous work has shown the participants to be
comparable to the general population (‘general population
recruitment group’)(13). To enrich the KOALA study with
women adhering to an alternative lifestyle, the study was
advertised through several speciﬁc channels, such as
organic food shops, anthroposophic general practitioners
and midwives, under-ﬁve clinics, Rudolf Steiner schools
and relevant magazines. Women interested in participating
were recruited from January 2002 until December 2002
without additional selection (‘alternative lifestyle recruit-
ment group’, n 491). Therefore, a total of 2834 women
were recruited in the KOALA study (i.e. 2343 from the
general population recruitment group and 491 from the
alternative lifestyle recruitment group). A possible selec-
tive participation of PPGP women in the KOALA study was
evaluated using a short questionnaire that allowed com-
parison of: (i) PPGP participants who did not participate in
the KOALA study; (ii) PPGP participants who accepted to
participate in the KOALA study; and (iii) KOALA partici-
pants from the alternative lifestyle recruitment group(14).
The results showed that the two former groups are com-
parable with each other and clearly different from the
latter in terms of prevalence of dietary habits deviating
from standard as deﬁned by including organic food and/or
being vegetarian or macrobiotic (4·2, 6·5 and 73·4%,
respectively).
All women were enrolled in the KOALA study between
14 and 18 weeks of gestation and received detailed
questionnaires on sociodemographic and health char-
acteristics at the time of recruitment and at 30 weeks of
pregnancy. At 34 weeks of pregnancy, an additional
questionnaire, dealing with lifestyle habits and focusing
mainly on dietary habits (FFQ), was sent to the women. In
all women recruited in both groups from January 2002
onwards, blood samples were collected around week 36
of pregnancy (n 1355 out of 2834 recruited in the KOALA
study, 47·8%). For the present analysis, data from both
questionnaires, from the FFQ and from the blood analysis
were needed. These data were available for 1346 (99·3%)
of the 1355 women who had provided a blood sample. To
enhance comparability with our previous work(9), mothers
of children who were stillborn or died as neonates (n 3) or
who had Down’s syndrome (n 4) were excluded. The
analyses presented here were therefore performed with
1339 women out of the 2834 initially recruited in the
KOALA study, 47·2%). Seventy-two per cent thereof
originated from the general population recruitment group
(965/1339, 72·1%), with the remaining ones (374/1339,
27·9%) having been recruited from the alternative lifestyle
recruitment group. All maternal data used in the KOALA
study were self-reported, except for information on
hypertension in pregnancy or gestational diabetes, which
was extracted from midwives’ reports.
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Organic groups’ deﬁnition
Among other items, the 34-week questionnaire included:
(i) items on adherence to ideological or religious rules,
including vegetarianism, veganism and anthroposophy;
(ii) a 198-item FFQ; and (iii) questions on the origin
(organic, conventional or other food-speciﬁc possibilities)
of seven food groups: meat, eggs, vegetables, fruit, milk
and milk products, bread, and dried food products (dried
legumes and cereals), as well as on the percentage of
organic origin of purchases of each food group: not at all,
less than 50%, between 50% and 90% or more than 90%.
The 198-item FFQ was an extended version of a
previously existing, validated FFQ(15). Relative to the
original FFQ, the extended version comprised several
additional items that can be expected to be more often
consumed by people with alternative lifestyles.
The level of organic food use was deﬁned based on the
questions concerning origin of most of the consumed items
and the percentage of organic products of all seven food
groups taken together, unless the respondents had reported
not to consume at least one of these groups. In this case,
only the consumed food groups were considered for the
deﬁnition of organic food use. The following three groups
of organic food purchase were deﬁned: (i) ‘<50% organic’
(n 441), if some food groups were of organic production,
but not all were reported as being more than 50% organic;
(ii) ‘50–90% organic’ (n 73), if 50% of all consumed food
groups was of organic production but not all >90%; and
(iii) ‘>90% organic’ (n 58), if more than 90% of all
consumed food groups was of organic production. As a
reference group for these three organic groups, we used the
fourth group of participants, namely those who purchased
all consumed food groups of conventional origin
(‘conventional’ group, n 767).
Choice of biomarkers
Biomarkers considered of public health relevance for
pregnant women at the time the KOALA mothers were
pregnant (years 2000 to 2002) were analysed: Fe, homo-
cysteine, 25-hydroxyvitamin D (25(OH)D), plasma lipids
(including TAG, total cholesterol, HDL cholesterol and
fatty acids). This analytical work was commissioned by the
Dutch Ministry of Health to the National Institute of Public
Health and the Environment.
Blood collection and analysis
Maternal blood was collected in EDTA-tubes at 34–36 weeks
of pregnancy. After centrifugation, the EDTA-plasma was
stored in cryovials at −80°C. Laboratory measurements were
done at the Laboratory for Toxicology and Nutrition,
National Institute of Public Health and the Environment
(Bilthoven, the Netherlands). The kits for quantiﬁcation of
TAG, total cholesterol and HDL cholesterol were from
Beckman Coulter (Mijdrecht, the Netherlands; numbers
445850, 467825 and 650207, respectively).
The measurements of TAG, total cholesterol, HDL
cholesterol and homocysteine were performed on an
autoanalyser (LX20 Pro; Beckman Coulter). Maternal fatty
acid status was assessed in plasma phospholipids, after
removing the plasma proteins by precipitation and
centrifugation. Fatty acid methyl esters were obtained
according to a standardised protocol wherein the sample
was extracted and subsequently hydrolysed and methyl-
ated with boron triﬂuoride. Hexane was added to extract
the fatty acid methyl esters, and these were separated
using a GC-3900 gas chromatograph (Varian Inc.,
Middelburg, the Netherlands) equipped with a CP 8400
auto injector. Galaxie software was used for quantiﬁcation
and identiﬁcation of peaks. Fatty acid concentrations are
expressed as proportions of total fatty acids (C14–C22)
present in the chromatogram (weight percentage, wt%).
Plasma ferritin was measured with an immunoanalyser
(Access-2; Beckman Coulter) using a Quantex kit (Ferritin
3000–2271; Biokit SA, Barcelona, Spain). This method has
a lowest detection limit of 6mg/l; 141 samples were below
this threshold, in which cases a value of 3 µg/l was
imputed. The kit for quantiﬁcation of homocysteine
(number 905510) was from Dialab, Vienna, Austria.
Plasma levels of 25(OH)D were determined with the
OCTEIA 25-Hydroxy Vitamin D ELISA kit from Immuno
Diagnostic Systems (Boldon, UK).
For each biomarker, the following inter-assay variation
values at the various levels were obtained: (i) TAG, 3·0% at
0·80mmol/l, 2·7% at 1·25mmol/l and 2·5% at 1·73mmol/l;
(ii) total cholesterol, 2·8% at 2·6mmol/l, 3·2% at 4·4mmol/l
and 2·7% at 6·0mmol/l; (iii) HDL cholesterol, 4·8% at
0·73mmol/l, 5·4% at 1·21mmol/l and 5·2% at 1·71mmol/l;
(iv) fatty acids, 14·9% for the fatty acids at 0·1–0·5%, 11·8%
at 0·5–2·0% and 2·0% at >2·0%; (v) ferritin, 3·8% at
61·1ng/ml and 3·0% at 277 ng/ml; (vi) homocysteine, 6·9%
at 6·8 µmol/l, 5·7% at 12·1 µmol/l, 2·8% at 28·9 µmol/l and
3·7% at of 39·1 µmol/l; and (vii) 25(OH)D, 7·5% at
21·7nmol/l and 5·8% at 84·6 nmol/l.
Statistical methods
The various participant groups were descriptively char-
acterised in terms of sociodemographic and lifestyle char-
acteristics (data shown in Tables 1 and 2). Unless indicated
otherwise, data were expressed as mean and SD. Differences
in values for numerical variables (e.g. BMI, biomarkers)
between the various organic groups and the reference
group were evaluated using linear regression with dummy
coding for level of organic food use, using an index variable
coded 1 to 4 for the conventional (reference), <50%,
50–90% and >90% organic groups, respectively, in the
linear regression. For categorical health-related variables,
the trend of increasing (or decreasing) proportions over the
above four dietary groups was tested by Kendall’s τc.
For each biomarker, a multivariable linear regression
model was deﬁned in which the following covariables were
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adjusted for: maternal parity and age (in all analyses) and
season when the questionnaire was ﬁlled in (only for dietary
markers expected to differ by season, such as the ruminant
fatty acids RA and VA(16) and vitamin D(17)). Moreover, for
long-chain fatty acids, ferritin, homocysteine and 25(OH)D,
we adjusted for supplement use of long-chain fatty acids, Fe,
vitamin B12 and vitamin D, respectively.
To discriminate between possible effects of food origin
(from conventional or organic production) v. those of the
(more or less healthy) food patterns, an additional model
was developed for each biomarker, in which two indica-
tors of a healthy diet were added as covariables. These
indicators consist of the scores corresponding to the two
components with the highest eigenvalues determined in a
principal component analysis performed with FFQ data
(see our previous work(9)). These were clearly dominating
in the scree plot, accounted for 6·1% of the variance in
food intake, and the corresponding scores were sig-
niﬁcantly higher or lower in all organic groups than in the
conventional (reference) group. They were named ‘alter-
native/vegetarian’ and ‘fast food’, respectively, and can be
seen as indicative of how healthy a diet is(9). Together,
they are comparable to the ‘health and sustainability’
component previously detected in the MoBa study, which
is close to the dietary recommendations for health as well
as ecological sustainability(10).
All data were analysed with the statistical software
package IBM® SPSS® Statistics Version 19.0 and two-tailed
P values <0·05 were considered statistically signiﬁcant.
Results
Sociodemographic characteristics
Mothers in the organic groups had a higher education
level, were older at delivery and had more often delivered
at least one child previously (Table 1). The large majority
of women of all four groups were of Dutch ancestry.
According to the recruitment methods (see ‘Study design
and participants’ section), relatively more women with a
fully conventional diet lived in southern provinces
(Limburg and Brabant) and relatively more women among
the organic groups lived in the mid-northern provinces
(Gelderland, Utrecht and others).
Associations between organic food consumption
and health-related characteristics
As expected from the recruitment methods, more women in
the organic groups adhered to living rules related to alter-
native lifestyles such as vegetarianism and anthroposophy
(Table 2). No signiﬁcant differences were found with regard
to alcohol consumption or active smoking. However, the
percentage of women who were exposed to passive smoke
at 34 weeks of pregnancy was lower in the organic groups
than in women consuming exclusively conventional food.
In the organic food groups, the average pre-pregnancy BMI
was signiﬁcantly lower than in the conventional (reference)
group (Table 2), with a clear difference already noticeable
in the <50% organic group (mean BMI 22·9 (SD 3·36) v. 23·8
(SD 3·92) kg/m2 in the conventional group, P< 0·001).
Table 1 Baseline sociodemographic characteristics of the pregnant women with varying purchases of food of organic v. conventional origin,
KOALA Birth Cohort Study, The Netherlands, 2000–2002 (n 1339)
Conventional (reference)
(n 767)
<50% organic
(n 441)
50–90% organic
(n 73)
>90% organic
(n 58)
Characteristic Mean or % SD or n Mean or % SD or n Mean or % SD or n Mean or % SD or n
Age of the mother at delivery
(years), mean and SD
32·0 3·60 32·9 3·91 34·1 4·17 32·5 3·85
Number of previous children
0 43·7 335 40·8 179 28·8 21 41·4 24
1 42·5 326 41·3 182 45·2 33 39·7 12
2 or more 13·8 106 17·7 80 26·0 19 18·9 11
Highest level of education
Lower or lower-middle (vocational) 8·4 64 5·4 24 11·0 8 5·2 3
Mid-higher (vocational) 38·5 295 30·4 134 20·5 15 27·6 16
Higher (high vocational or academic) 49·7 381 59·9 264 63·0 46 63·8 37
Others 3·5 27 4·3 19 5·5 4 3·4 2
Mother born in the Netherlands 97·8 743 94·6 417 94·5 69 93·1 54
Living area (province)
South (Limburg) 41·1 315 29·7 131 17·8 13 17·2 10
Mid-south (Brabant) 37·7 289 25·9 114 24·7 18 20·7 12
Mid-east and mid-north
(Gelderland, Utrecht and other provinces)
21·3 162 44·2 195 57·6 42 61·8 36
Season when FFQ was filled out*
Spring 19·9 153 18·6 82 17·8 13 20·7 12
Summer 20·5 157 25·6 113 21·9 16 31·0 18
Autumn 26·5 203 28·6 126 30·1 22 24·1 14
Winter 33·1 254 27·2 120 30·1 22 24·1 14
Data are presented as % and n, unless indicated otherwise.
Missing data: for mother born in the Netherlands, n 1 in the conventional group; for living area (province), n 1 in the <50% organic group.
*Spring, 1 March–31 May; summer, 1 June–31 August; autumn, 1 September–30 November; winter, 1 December–end February. Blood sampling occurred two
weeks after filling out the FFQ.
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In all groups, most women showed a BMI within the normal
range (18·5–24·9 kg/m2), but there was a higher proportion
of women with a normal BMI in the organic groups than in
the conventional (reference) group.
The occurrence of hypertension did not seem to differ
among the groups. However, in the organic groups, fewer
participants suffered from diabetes in pregnancy than in the
conventional (reference) group. Well-known risk factors for
CVD such as alcohol consumption, smoking (see Table 2)
and Na consumption (data not shown) were comparable in
the various groups. Moreover, adjusting for smoking and
alcohol did not affect the results.
Association between organic food consumption
and biomarkers
While total cholesterol and HDL cholesterol were not sig-
niﬁcantly different among the groups, LDL cholesterol was
signiﬁcantly higher in the organic groups. The levels of
several individual fatty acids also varied among the
different groups. On the one hand, the levels of penta-
decanoic acid (15 : 0), VA (18 : 1n-7,trans), linoleic acid
(LA; 18 : 2n-6,cis) and RA (18 : 2n-7,trans,n-9,cis) were
signiﬁcantly higher in some organic groups relative to the
conventional (reference) group. On the other hand, the
levels of elaidic acid (EA; 18 : 1n-9,trans), α-linolenic acid
(ALA; 18 : 3n-3) and arachidonic acid (AA; 20 : 4 n-6) were
signiﬁcantly lower in the organic groups compared with the
conventional one. The levels of DHA (22 : 6n-3) appeared
to be lower in the organic groups; the trend over the groups
attained statistical signiﬁcance only when the covariates
were considered. Relative to the conventional (reference)
group, the organic groups had a markedly lower EA:VA
(18 : 1n-9,trans:18 : 1n-7,trans), a marker of industrial v.
natural origin of dietary trans-fatty acids (Table 3).
Table 2 Lifestyle and health-related characteristics of pregnant women with varying purchases of food of organic v. conventional origin,
KOALA Birth Cohort Study, The Netherlands, 2000–2002 (n 1339)
Conventional (reference)
(n 767)
<50% organic
(n 441)
50–90% organic
(n 73)
>90% organic
(n 58)
Characteristic % or mean n or SD % or mean n or SD % or mean n or SD % or mean n or SD
Lifestyle characteristics
Alternative group 10·2 78 47·6 210 68·5 50 56·9 36
Adheres to living rules 1·7 13 16·6 72 32·4 23 43·1 25
Identifies with anthroposophy 0·4 3 6·3 28 13·7 10 19·0 11
Vegetarianism 1·4 11 8·8 39 17·8 13 24·1 14
Veganism 0·1 1 0·0 0 0·0 0 0·0 0
Alcohol consumption during pregnancy (glasses/d)
0 81·9 628 80·5 355 79·5 58 84·5 49
1 11·0 84 11·8 52 12·3 9 6·9 4
2 4·3 33 3·6 16 5·5 4 5·2 3
3 1·3 10 1·8 8 0·0 0 1·7 1
4 or more 1·6 12 2·3 10 2·7 2 1·7 1
Active maternal smoking during pregnancy (cigarettes/d)
0 93·7 719 96·6 426 93·2 68 96·6 56
1–5 2·1 16 2·0 9 2·7 2 0·0 0
6–10 3·0 23 0·7 3 4·1 3 1·7 1
11–15 0·8 6 0·7 3 0·0 0 1·7 1
16–20 0·4 3 0·0 0 0·0 0 0·0 0
Passive maternal smoking during pregnancy
Rare, <1 h/week 66·2 505 76·7 335 80·6 56 86·2 50
Occasionally, but <1 h/d 23·5 179 18·1 79 21·5 9 6·9 4
On average, 1–4h/d 8·0 61 4·3 19 6·9 5 6·9 4
On average, >4h/d 2·4 18 0·9 4 0·0 0 0·0 0
Health-related outcomes
Height (cm), mean and SD 169·9 6·22 170·0 6·68 170·0 6·06 169·5 6·48
BMI before pregnancy (kg/m2)†, mean and SD 23·8 3·92 22·9 3·36 22·5 3·80 22·6 3·32
Underweight (<18·5kg/m2)‡ 3·4 26 2·5 11 2·7 2 1·7 1
Normal (18·5–24·9 kg/m2)‡ 67·3 514 76·8 337 80·8 59 77·6 45
Overweight (25·0–29·9 kg/m2)‡ 20·9 160 15·7 69 11·0 8 17·2 10
Obesity (≥30 kg/m2)‡ 8·4 54 5·0 22 5·5 4 3·4 2
Hypertension in pregnancy 4·3 33 3·9 17 1·4 1 3·4 2
Diabetes in pregnancy§ 2·0 15 0·5 2 0·0 0 0·0 0
Data are presented as % and n, unless indicated otherwise.
Missing data: for adheres to living rules, n 2, n 7, n 2 and n 0 in the conventional, <50% organic, 50–90% organic and >90% organic group, respectively;
for height, n 1 in the conventional group; for BMI before pregnancy, n 3 and n 2 in the conventional and <50% organic group, respectively; for hypertension, n 3
in the conventional group; for diabetes, n 2 in the conventional group.
†P<0·001 before and after adjustment for maternal age, parity, alcohol consumption and smoking; to calculate statistical significance, linear regression was used
with dummy variables indicating the comparison of each organic group with the conventional (reference) group, and the trend over the groups was tested using an
index variable coded 1 to 4 for the conventional (reference) group and the <50%, 50–90% and >90% organic groups, respectively, in the linear regression.
‡P<0·001 considering all four groups defined according to BMI values; to test the trend of increasing or decreasing percentages over the groups, Kendall’s τc for
categorical variables was applied, with the groups coded 1 to 4 (as mentioned under †).
§P=0·002 (as in ‡).
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Compared with the conventional (reference) group, the
blood level of ferritin (Table 3) was lower in the <50% and
50–90% organic groups but higher in the >90% organic
group. Homocysteine was signiﬁcantly lower in the <50%
and 50–90% organic groups; the test for trend over the
groups was signiﬁcant in the crude model but lost sig-
niﬁcance when adjusting for maternal age, parity
(numerical) and vitamin B12 supplements (Table 3). Blood
25(OH)D level was lower in the 50–90% organic group;
after adjustment, this was observed in the >90% organic
group as well (P trend over categories <0·001).
After adjusting for the healthy diet indicators (compo-
nents ‘alternative/vegetarian’ and ‘fast food’ from principal
component analysis), the differences and their statistical
signiﬁcance were retained in the cases of 25(OH)D, 15 : 0
and VA. However, in the cases of homocysteine, LDL
cholesterol, EA, LA, ALA, AA and EA:VA, the differences
were attenuated and lost signiﬁcance, indicating that the
association between these blood markers and organic
intake was at least partly due to differences in food
pattern. Interestingly, the ‘fast food’ component was solely
responsible for the attenuation of the differences between
homocysteine in the organic groups, whereas in the other
cases both components played a role (data not shown).
Discussion
Consumption of organic food was associated with a more
favourable pre-pregnancy BMI, lower prevalence of
overweight and obesity before pregnancy and a lower
prevalence of diabetes in pregnancy. Moreover, several
differences concerning blood biomarkers were observed.
We previously found(9) that women consuming organic
food during pregnancy had a food intake pattern
comprising more products of vegetable origin – soya/
vegetarian products, vegetables, cereal and cereal pro-
ducts, bread, fruits, legumes – and fewer animal products
– milk and milk products, meat and meat products – than
women consuming conventional diets. A principal
component analysis performed on the consumed food
items conﬁrmed these results. Most interestingly, scores
corresponding to the ﬁrst two main components found,
‘alternative/vegetarian’ and ‘fast food’, were markedly
higher and lower, respectively, in the organic groups in
comparison with the conventional (reference) group.
Differences in food patterns are likely to have translated
into differences in nutrient intakes among groups which,
in time, could possibly contribute to the differences in
blood biomarkers and health-related outcomes found in
the present study.
Study strengths and limitations
Twenty-eight per cent of the participants considered in the
present analysis were actively recruited using channels
that are likely to address persons with alternative lifestyles
(alternative lifestyles recruitment group). This was done to
provide a deeper insight into the characteristics of this
speciﬁc part of the population and to increase contrast in
related exposure variables such as nutrition. Furthermore,
this allowed us to compare a wide range of users of
organic products, ranging from occasional users to very
consistent users, which enabled our previous work on
food patterns and intake(9). The enrichment of the cohort
with participants with alternative lifestyles may have led to
some overestimation of the differences found between
some organic groups and the conventional group.
Nevertheless, the clear differences observed between the
group of participants with only moderate consumption of
organic foods (<50%) and the conventional (reference)
group indicates a considerable generalizability of our
observations. Moreover, in our previous work(9), we
demonstrated that almost a third (29%) of the participants
from the general population recruitment group consumed
at least some food of organic origin. This shows that a
signiﬁcant portion of the general population used organic
food products at the time of the study, indicating a high
applicability of the present results. Further strengths of the
present work comprise the high number of participants
and the very detailed FFQ.
A limitation of the present study concerns the different
time points of the assessment of diet patterns (pregnancy
week 34) and health-related characteristics (mostly in
pregnancy week 30). The BMI value used in the present
analysis is calculated based on the weight before preg-
nancy. Whereas this enables a BMI comparison between
the groups, the value of the comparison depends on the
assumption that intake of organic food during pregnancy
was comparable to that before pregnancy. Concerning the
women who consumed organic food before pregnancy, it
is unlikely that they stopped this upon knowing that they
were pregnant. In contrast, it is conceivable that some
women who did not consume organic products before
pregnancy would have started to do so afterwards. How-
ever, this would have led to an underestimation of the
differences between the participants from the organic
group and those of the conventional group. An additional
limitation is that no information on physical activity was
available and therefore explanations of differences related
to energy intake/expenditure are only speculative.
BMI, hypertension and diabetes in pregnancy
Although we lack data on energy expenditure and there-
fore cannot be sure that the differences in pre-pregnancy
BMI between the groups are due to diet, a lower BMI in
the organic groups would ﬁt with the consumption of less
products from animal origin and more from plant origin(9).
These factors are known to be associated with a decreased
risk for cardiovascular events, diabetes and all-cause
mortality(18). Strong inverse associations between dietary
ﬁbre intake and the cardiovascular risk factors excessive
weight gain, central adiposity, high TAG, low HDL
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Table 3 Plasma levels of various biomarkers in pregnant women with varying purchases of food of organic v. conventional origin, KOALA Birth Cohort Study, The Netherlands, 2000–2002
(n 1339)
Conventional (reference)
(n 767)
<50% organic
(n 441)
50–90% organic
(n 73)
>90% organic
(n 58) Trend
Biomarker Mean SD B 95% CI B 95% CI B 95% CI P
TAG (mmol/l)
Crude 3·20 1·011 −0·114 −0·232, 0·003 −0·126 −0·366, 0·114 −0·064 −0·333, 0·205 0·125
Adjusted −0·108 −0·226, 0·011 −0·132 −0·374, 0·110 −0·087 −0·358, 0·185 0·111
Total cholesterol (mmol/l)
Crude 6·97 1·307 0·016 −0·142, 0·173 0·158 −0·165, 0·481 0·349 −0·010, 0·709 0·074
Adjusted 0·002 −0·157, 0·161 0·138 −0·188, 0·465 0·319 −0·045, 0·682 0·128
HDL cholesterol (mmol/l)
Crude 1·76 0·446 −0·038 −0·090, 0·013 −0·042 −0·147, 0·064 −0·046 −0·163, 0·072 0·152
Adjusted −0·044 −0·143, 0·087 −0·076 −0·312, 0·120 −0·043 −0·220, 0·306 0·100
LDL cholesterol (mmol/l)
Crude 3·76 1·229 0·108 −0·041, 0·257 0·255 −0·050, 0·559 0·412 0·071, 0·753 0·004
Adjusted 0·098 −0·052, 0·248 0·236 −0·071, 0·543 0·404 0·059, 0·749 0·007‡
15 : 0 (pentadecanoic acid; wt%)†
Crude 0·25 0·056 0·035 0·028, 0·042 0·055 0·040, 0·069 0·046 0·030, 0·062 <0·001
Adjusted 0·033 0·026, 0·040 0·050 0·035, 0·064 0·039 0·023, 0·055 <0·001
18 : 1n-9,cis (OA; wt%)*
Crude 9·38 1·073 0·104 −0·022, 0·230 −0·262 −0·521, −0·004 0·021 −0·266, 0·309 0·880
Adjusted 0·121 −0·006, 0·247 −0·217 −0·478, 0·043 0·058 −0·232, 0·348 0·782
18 : 1n-9,trans (EA; wt%)*
Crude 0·404 0·2539 −0·051 −0·077, −0·026 −0·066 −0·118, −0·014 −0·100 −0·158, −0·043 <0·001
Adjusted −0·045 −0·070, −0·019 −0·051 −0·103, 0·002 −0·081 −0·139, −0·023 <0·001‡
18 : 1n-7,trans (VA; wt%)*
Crude 0·185 0·0630 0·007 −0·001, 0·015 0·026 0·010, 0·043 0·037 0·019, 0·055 <0·001
Adjusted 0·004 −0·004, 0·011 0·022 0·007, 0·038 0·031 0·013, 0·048 <0·001
18 : 2n-6,cis (LA; wt%)*
Crude 20·84 2·210 0·219 −0·047, 0·485 1·027 0·483, 1·572 0·746 0·140, 1·351 <0·001
Adjusted 0·186 −0·080, 0·452 0·926 0·381, 1·476 0·695 0·086, 1·305 0·001‡
18 : 2n-7,trans,n-9,cis (RA; wt%)*
Crude 0·034 0·0229 0·006 0·003, 0·009 0·003 −0·003, 0·009 0·005 −0·002, 0·012 0·006
Adjusted 0·006 0·003, 0·009 0·003 −0·003, 0·009 0·006 −0·001, 0·013 0·001‡
18 : 3n-3 (ALA; wt%)*
Crude 0·280 0·0872 −0·002 −0·013, 0·008 −0·017 −0·038, 0·004 −0·029 −0·052, −0·005 0·014
Adjusted −0·001 −0·012, 0·009 −0·016 −0·035, 0·008 −0·027 −0·051, −0·003 0·035‡
20 : 3n-6 (wt%)*
Crude 3·41 0·587 0·006 −0·063, 0·075 0·009 −0·133, 0·150 −0·009 −0·167, 0·148 0·965
Adjusted 0·016 −0·053, 0·086 0·034 −0·109, 0·177 0·015 −0·144, 0·179 0·612
20 : 4n-6 (AA; wt%)*
Crude 7·72 1·275 −0·409 −0·557, −0·262 −0·565 −0·867, −0·262 −0·387 −0·723, −0·051 <0·001
Adjusted −0·405 −0·553, −0·257 −0·573 −0·877, −0·270 −0·340 −0·678, −0·002 <0·001‡
20 : 5n-3 (EPA; wt%)*
Crude 0·424 0·2764 0·010 −0·024, 0·044 0·009 −0·061, 0·078 −0·006 −0·083, 0·071 0·811
Adjusted 0·006 −0·028, 0·040 0·005 −0·065, 0·074 −0·025 −0·102, 0·053 0·832
22 : 4n-6 (wt%)*
Crude 0·390 0·0966 0·003 −0·009, 0·014 −0·005 −0·029, 0·018 <0·001 −0·026, 0·026 0·987
Adjusted 0·005 −0·007, 0·016 −0·001 −0·025, 0·022 0·008 −0·018, 0·037 0·486
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Table 3 Continued
Conventional (reference)
(n 767)
<50% organic
(n 441)
50–90% organic
(n 73)
>90% organic
(n 58) Trend
Biomarker Mean SD B 95% CI B 95% CI B 95% CI P
22 : 5n-3 (wt%)*
Crude 0·535 0·1204 −0·002 −0·017, 0·014 −0·022 −0·054, 0·009 −0·020 −0·055, 0·015 0·143
Adjusted −0·002 −0·017, 0·013 −0·021 −0·053, 0·010 −0·025 −0·060, 0·010 0·110
22 : 6n-3 (DHA; wt%)*
Crude 3·91 0·837 −0·068 −0·169, 0·033 −0·141 −0·348, 0·065 −0·104 −0·334, 0·126 0·086
Adjusted −0·079 −0·179, 0·021 −0·146 −0·351, 0·059 −0·173 −0·401, 0·053 0·027
18 : 1 n-9,trans:18 : 1n-7,trans (EA:VA; wt%/wt%)*
Crude 2·30 1·318 −0·23 −0·400, −0·064 −0·52 −0·860, −0·170 −0·66 −1·039, −0·272 <0·001
Adjusted −0·15 −0·321, 0·013 −0·37 −0·716, −0·031 −0·49 −0·866, −0·103 0·001‡
Ferritin† (ln, ng/ml)
Crude 2·37 0·966 −0·016 −0·131, 0·100 −0·088 −0·321, 0·151 0·087 −0·176, 0·350 0·999
Adjusted −0·028 −0·143, 0·087 −0·076 −0·312, 0·160 0·043 −0·220, 0·306 0·804
Homocysteine (µmol/l)
Crude 9·35 3·791 −0·465 −0·902, −0·028 −1·086 −1·981, −0·190 −0·763 −1·759, 0·232 0·004
Adjusted −0·267 −0·706, −0·173 −0·843 −1·740, −0·055 −0·454 −1·453, 0·545 0·064
25(OH)D (nmol/l)
Crude 44·4 18·15 −0·370 −2·502, 1·762 −5·233 −9·599, −0·868 −4·331 −9·185, 0·522 0·019
Adjusted −0·140 −3·266, 0·465 −4·638 −8·457, −0·818 −6·433 −10·681, −2·185 <0·001
OA, oleic acid; EA, elaidic acid; VA, vaccenic acid; LA, linoleic acid; RA, rumenic acid; ALA α-linolenic acid; AA, arachidonic acid; 25(OH)D, 25-hydroxyvitamin D; CLA, conjugated linoleic acids (18 : 2 conjugated isomers).
Data are presented as mean and SD in the conventional (reference) group and as mean difference values and 95% CI in the three organic groups. Fatty acids are expressed as percentage of total blood fatty acids.
Significant results (P< 0·05 or CI not including the null value, which is equivalent to P< 0·05) are shown in bold font.
Unadjusted values are crude B; adjusted values controlled for the following covariates. Total cholesterol, HDL cholesterol, LDL cholesterol and TAG: maternal age, parity (numerical), alcohol consumption (numerical) and
smoking (numerical). Single fatty acids (except VA, CLA and EA:VA), homocysteine and vitamin E: maternal age and parity (numerical); since only a few participants took fatty acids supplements (n 7 in the conventional
group, n 6 in the <50% organic and n 1 in the >90% organic group), these were not considered as covariates. Ferritin (logarithmic): maternal age, parity (numerical) and Fe supplements (as dummies). Homocysteine:
maternal age, parity (numerical) and vitamin B12 supplements. 25(OH)D: maternal age, parity (numerical), season (as dummies) and vitamin D supplements (as dummies). Ruminant fatty acids (VA, CLA and EA:VA):
maternal age, parity (numerical) and season (as dummies).
Data were missing as follows. For conventional group: total cholesterol and homocysteine, n 1; 25(OH)D, n 2; HDL cholesterol, n 3; TAG, n 4; RA, n 90. For <50% organic group: 25(OH)D and TAG, n 1; RA, n 45.
For 50–90% organic group, n 5. For >90% organic group: RA, n 6.
*Weight percentage of total fatty acids in plasma phospholipids.
†Ferritin concentration in the conventional (reference) group was 15·9 (SD 17·85) ng/ml. Since this variable had a markedly skewed distribution, the natural logarithm was calculated and shown in the table.
‡Lost significance when healthy diet indicators were added to the adjusted model.
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cholesterol, high LDC cholesterol and elevated blood
pressure have been shown(18).
In the present study, no linear trend for a different
prevalence of hypertension during pregnancy was
observed over the organic groups, but the 50–90% organic
group showed a lower prevalence than the other groups.
In recent meta-analyses of associations between food
intake and hypertensive disorders in pregnancy, the
authors came to the conclusion that lower Mg and Ca
intake measured during pregnancy might be associated
with hypertension(20,21). We showed that the intake of
these micronutrients was higher in the organic groups(9).
The lower prevalence of pregnancy diabetes in the
organic groups is in line with the lower BMI and several
diet characteristics. Since diabetes in pregnancy is usually
diagnosed around 26 week of pregnancy and, upon
diagnosis, intensive dietetic counselling is likely to occur, a
sensitivity analysis was performed to ﬁnd out whether this
diagnosis could have affected the diet. When excluding
women with pregnancy diabetes from the analysis, the
results remained unchanged (data not shown).
Blood lipids and fatty acids
In this section and below, we focus on blood biomarkers
that differed by at least 10% in one or more of the organic
groups relative to the conventional (reference group) and
relate these to our previously reported differences in food
and nutrient intake(9) (see Table 4).
Blood lipid analyses showed statistically signiﬁcant
higher levels of LDL cholesterol in the organic groups, the
difference between the >90% group and the conventional
(reference) group being 11%, with a signiﬁcant test for
trend (Table 4). The reason for these higher levels in the
organic groups is unclear. The SFA 15 : 0 is considered to
be a marker of dairy intake since its main dietary source is
cows’ milk butterfat(22). 15 : 0 was found to be higher in the
organic groups (Table 4), consistent with the higher intake
of cheese(9) and of whole-milk products including butter
(data not shown). The lower blood levels of ALA are
surprising, since the usual sources of this fatty acid would
be expected to play a relatively bigger role in the organic
nutrition. Our previous food intake analysis, however, did
not conﬁrm higher intakes of seeds, nuts and oils in the
organic groups(9). Although the ALA intake in the 50–90%
and >90% organic groups was numerically lower than in
the reference group, the differences did not reach statis-
tical signiﬁcance.
We used EA:VA as a marker of industrial v. natural
trans-fatty acid intake. Industrial trans-fatty acids originate
from partially hydrogenated vegetable oils (industrially
hardened fats; e.g. EA) whereas natural trans-fatty acids
are derived mainly from ruminant fat intake (dairy, rumi-
nant meat; mainly VA and RA). The lower plasma EA:VA
ratio observed in the organic groups is consistent with the
lower EA:VA observed in breast milk from women
consuming organic products(4,23), and with the higher VA
intake and lower EA intake observed in the organic groups
compared with the conventional (reference) group(9). The
lower EA:VA intake in the organic groups is probably
related to the higher intake of cheese and takes place even
though the food pattern of the organic groups comprises
lower amounts of other milk products and meat(9). In face
of these results, we conducted a new, single-item analysis
of butter and margarine intake in the various groups to
investigate whether there was a preference for a certain
type of fat in the various groups. In the organic groups,
there was a higher intake of butter and a lower intake of
margarine relative to the conventional (reference) group
(data not shown).
Finally, organic milk products and meat were shown to
be particularly rich in RA and VA(24–26). A recent meta-
analysis conﬁrmed the higher levels of CLA (18 : 2
conjugated isomers) in organic milk and indicated that the
higher grazing/conserved forage intakes were the main
reason for the observed differences between organic and
Table 4 Point-by-point comparison between the main differences* in biomarker plasma values detected in the present work in the organic
groups v. the conventional (reference) group and previously observed tendencies in the corresponding micronutrient and food intake(9),
KOALA Birth Cohort Study, The Netherlands, 2000–2002 (n 1339)
Blood level in
organic groups v.
conventional
Micronutrient intake
in organic groups v.
conventional Food intake in organic groups v. conventional
15 : 0 (pentadecanoic acid) ↑ 15 : 0 ↑ Cheese ↑ (even though total milk and milk products ↓)
18 : 2n-7,trans,n-9,cis (RA) ↑† Total CLA ↑ Cheese ↑ (even though total milk and milk products ↓)
18 : 3n-3 (ALA) ↓† ALA ↔ –
18 : 1n-9,trans (EA) ↓† EA ↓ Fast food ↓
18 : 1n-7,trans (VA) ↑ VA ↑ Cheese ↑ (even though total milk and milk products ↓)
18 : 1n-9,trans:18 : 1n-7, ↓† EA:VA ↓ Fast food ↓
trans (EA:VA) Cheese ↑ (even though total milk and milk products ↓)
Homocysteine (µmol/l) ↓† Folate ↑ Vegetable products ↑
25(OH)D (nmol/l) ↓ Vitamin D ↓ Meat, fish and total milk products ↓
RA, rumenic acid; ALA α-linolenic acid; EA, elaidic acid; VA, vaccenic acid; 25(OH)D, 25-hydroxyvitamin D; ↑, increased; ↓, decreased; CLA, conjugated linoleic
acids (18 : 2 conjugated isomers); ↔ , no difference.
*That is, trend is statistically significant and consistent over the three organic groups and difference corresponds to at least 10% of the reference value in at
least one organic group, either in the crude or in the main adjusted model.
†Adjustment for healthy diet indicators (components ‘alternative/vegetarian’ and ‘fast food’ from principal component analysis) attenuated the differences.
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conventional milk(26). Therefore, and since the differences
between the organic groups and the conventional
(reference) group were not attenuated by adjusting for
the healthy diet indicators (components ‘alternative/
vegetarian’ and ‘fast food’ from principal components
analysis), it is conceivable that the origin of milk products
and meat has contributed to the higher plasma levels of
VA in the organic groups.
Other blood biomarkers
The blood ferritin values were only slightly lower in the
organic groups than in the reference group (ln of the
concentration in ng/ml at most 0·088 lower than the mean
value of 2·37 in the reference group; therefore not shown
in Table 4). In the organic groups, intake of haem Fe was
markedly lower than in the conventional group, the
opposite happening with non-haem Fe(9). Taken together,
this indicates that the well-known different absorption of
the two types of Fe – haem and non-haem – is being
somehow compensated for.
The amounts of dietary folate ingested in the organic
groups were higher than in the conventional group
(between 288 and 300 µg/d in the organic groups, 265 µg/d
in the conventional group) and close to the daily require-
ments for adult women (about 300 µg/d). The lower blood
values of homocysteine detected in the organic groups
could be explained by the higher intake of dietary folate.
On the contrary, the somewhat lower levels of ingested
vitamin B12 in the organic groups did not result in higher
homocysteine levels.
The lower blood levels of 25(OH)D in the organic groups
are likely to be related to the lower amounts of ﬁsh con-
sumed, since fatty ﬁsh is an important source of vitamin D. In
addition, the lower intake of milk products in the organic
groups could have played a role as well, given that Ca is
necessary for the dermal conversion from 7-dehydrochol-
esterol into 25(OH)D. These results are, however, difﬁcult to
interpret because information on sunlight exposure, a major
trigger of 25(OH)D synthesis, is missing. Lower blood levels
of 25(OH)D in the organic group were not compensated by
higher use of vitamin D supplements(9).
Possible implications for health
Overall, our results suggest that consumption of organic
products has a positive impact on health, whereby the
associated food intake pattern, rather than the organic pro-
ducts per se, is likely to play a prominent role. Especially in
relation to the biomarkers RA, ALA, EA and homocysteine, a
healthier diet pattern – deﬁned by high scores of the ‘alter-
native/vegetarian’ component and low scores of the ‘fast
food’ component – can be assumed responsible for the
observed differences between organic groups and the con-
ventional (reference) group, since adjusting for it attenuated
the differences. In the cases in which no attenuation or loss
of signiﬁcance was observed, no conclusions can be drawn
on the origin of the differences in biomarker levels between
the groups; either the reason was not related to the food
patterns or our approach to compensate for the effect of
healthier food patterns was not powerful enough to correct
for it.
The lower prevalence rates of overweight and obesity in
the organic groups are particularly interesting, since over-
weight and obesity are known risk factors for an adverse
pregnancy outcome(27,28) and CVD in women(29). Pre-
pregnancy weight is one of the maternal characteristics sig-
niﬁcantly associated with newborn cardiometabolic traits(30).
Furthermore, in the full-term placenta, maternal obesity
affects placental fatty acid uptake, which may modify the
fetal metabolism(31). Maternal overweight/obesity is there-
fore not only relevant for the woman’s health, but also for
the offspring’s predisposition for diseases in later life.
The comparatively higher intake of trans-fatty acids
derived from ruminant fat (i.e. mainly VA and RA) and the
lower intake of trans-fatty acids from partially hydro-
genated vegetable oils (marker EA) in the organic groups
might have a long-term positive effect on the risk of CVD.
Trans-fatty acids from partially hydrogenated vegetable
oils can contribute to pathological situations, such as
IHD(32) and type 2 diabetes(33). A meta-analysis of cohort
studies comparing the effect of industrial v. ruminant
trans-fatty acids on CHD suggested that ruminant trans-
fatty acids had favourable effects(33). Whether the plasma
levels of the various trans-fatty acids are related to the
observed differences in BMI, prevalence of overweight,
obesity and gestational diabetes deserves further investi-
gations. It is conceivable that the intake of trans-fatty acids
from partially hydrogenated vegetable oils in the normal
population is already lower than at the time participants
were being recruited to participate in the KOALA study,
since the European industry had just started lowering
trans-fats in processed food products on a voluntary basis.
In the Netherlands, the lowering of trans-fatty acids
contents started in the 1990s with retail margarines and
frying fats, and continued after 2000 with other consumer
food products(35).
Folate intake before conception is important for the
offspring’s health. The higher intake of folate in the organic
groups during pregnancy(9), together with the observed
lower plasma levels of homocysteine, might be relevant,
especially if one assumes that women who consume
organic products during pregnancy are more likely to do so
as well before becoming pregnant.
Due attention should be paid to the lower intake and
blood levels of 25(OH)D in the organic groups in view of
the importance of this vitamin for the growing embryo/
fetus. In principle, these lower levels could be due to a
reduced adherence to taking vitamin D supplements and,
in our previous work(9), we observed different intakes of
vitamin D supplements among the various groups.
Whereas low-dose supplements were more often used in
the organic groups, supplements according to the recom-
mendation of taking 10 µg/d in pregnancy were consumed
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more seldom. Neither adjusting for vitamin D supplements
(Table 3) nor for healthy diet indicators, however, dimin-
ished the statistical signiﬁcance of the results on the blood
levels of vitamin D. In addition to the vitamin D supple-
ments issue, an interference of the season in which the
participants of the various groups have been recruited is
conceivable. It should however be noticed that adjusting
for season did not attenuate the statistical signiﬁcance of the
results (Table 3). A tighter control of 25(OH)D status of
pregnant women consuming organic products appears
therefore advisable. However, with respect to possible
consequences to the offspring, new observations suggest
that the fetus might regulate 25(OH)D metabolites inde-
pendently of the maternal blood level of 25(OH)D(36).
Nowadays, a global transformation of traditional diets can
be observed, in which the intake of meats, oils, reﬁned fats
and reﬁned sugars is increasing. This transition goes hand-
in-hand with various human health risks and low environ-
mental sustainability, with the interplay among diet, health
and environment becoming more and more apparent(37).
According to these authors, there are already plausible
solutions to this diet–environment–health trilemma, namely
alternative diets such as the Mediterranean, pescetarian and
vegetarian diets. Should these diets be adopted by more
people, this would positively affect both global environ-
mental and public health(37). The food pattern that we found
to be associated with the consumption of organic food
exhibits various similarities with these diets(9) and might
constitute an additional solution to improve human health
and to increase environmental sustainability.
Conclusions
Our work shows that consumption of organic products
during pregnancy is associated with more favourable pre-
pregnancy BMI and lower prevalence of overweight and
gestational diabetes. Further favourable aspects associated
with the consumption of organic food are lower plasma
level of a trans-fatty acid marker of industrially hydro-
genated fats (EA) and higher plasma levels of markers of
trans-fatty acids from natural origin, as well as lower
plasma levels of homocysteine, which may be indicative
of higher folate intake. Attention should be given to the
relatively lower plasma levels of 25(OH)D of pregnant
women consuming organic products.
Our results also give a clue on how speciﬁc food intake
patterns associated with the consumption of organic pro-
ducts are likely to play a major role in the observed
associations between the consumption of organic pro-
ducts and health-related outcomes.
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